Get the Stockscreener App
4.93
0.20%
-0.01
Pulmatrix Inc stock is traded at $4.93, with a volume of 6,767.
It is down -0.20% in the last 24 hours and up +1.44% over the past month.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
See More
Previous Close:
$4.94
Open:
$4.9
24h Volume:
6,767
Relative Volume:
0.57
Market Cap:
$18.01M
Revenue:
$11.68M
Net Income/Loss:
$-8.85M
P/E Ratio:
-2.0456
EPS:
-2.41
Net Cash Flow:
$-14.61M
1W Performance:
+1.86%
1M Performance:
+1.44%
6M Performance:
-25.42%
1Y Performance:
+124.09%
1-Day Range:
$4.83
$4.98
1-Week Range:
$4.81
$4.98
52-Week Range:
$2.00
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Name
Pulmatrix Inc
Sector
Industry
Phone
(888) 355-4440
Address
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
4.93 | 18.04M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-18 | Initiated | H.C. Wainwright | Buy |
Pulmatrix Inc Stock (PULM) Latest News
Real time pattern detection on Pulmatrix Inc. stock2025 Volatility Report & Weekly Hot Stock Watchlists - newser.com
How Pulmatrix Inc. (2PU) stock responds to bond market2025 AllTime Highs & Stepwise Trade Signal Implementation - newser.com
Will breakout in Pulmatrix Inc. lead to full recoveryTake Profit & Fast Entry High Yield Tips - newser.com
Is it time to cut losses on Pulmatrix Inc.Trade Analysis Report & Fast Moving Stock Trade Plans - newser.com
Trend analysis for Pulmatrix Inc. this weekJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - newser.com
Why institutional investors increase stakes in Pulmatrix Inc. (2PU) stockQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com
Is Pulmatrix Inc. stock attractive for long term wealth buildingPortfolio Update Summary & AI Forecast for Swing Trade Picks - newser.com
Is it too late to sell Pulmatrix Inc.Trade Performance Summary & Safe Entry Zone Identification - newser.com
What recovery options are there for Pulmatrix Inc.Portfolio Risk Summary & Real-Time Market Sentiment Reports - newser.com
Will Pulmatrix Inc. stock recover after recent dropTreasury Yields & Proven Capital Preservation Tips - newser.com
Will Pulmatrix Inc. stock go up soonM&A Rumor & AI Driven Price Forecasts - newser.com
What drives Pulmatrix Inc 2PU stock priceProtective Put Strategies & Minimize Portfolio Damage with Warnings - earlytimes.in
Why Pulmatrix Inc. stock attracts high net worth investorsJuly 2025 Macro Moves & Daily Growth Stock Tips - newser.com
Is Pulmatrix Inc. stock gaining market share2025 Price Momentum & Consistent Income Trade Ideas - newser.com
Evaluating Pulmatrix Inc. with trendline analysisTrade Entry Summary & Technical Pattern Alert System - newser.com
Will Pulmatrix Inc. stock deliver consistent dividends2025 Buyback Activity & Precise Buy Zone Tips - newser.com
Is Pulmatrix Inc. (2PU) stock prepared for digital transitionCPI Data & Reliable Breakout Forecasts - newser.com
Why Pulmatrix Inc. (2PU) stock is a strong buy callLong Setup & Weekly Watchlist of Top Performers - newser.com
Is Pulmatrix Inc. stock a good choice for value investors2025 Stock Rankings & Growth Oriented Trading Recommendations - newser.com
Pulmatrix Announces First Quarter 2022 Financial Results and Pro - GuruFocus
Using RSI to spot recovery in Pulmatrix Inc.July 2025 Decliners & Momentum Based Trading Signals - newser.com
Pulmatrix Inc Stock (PULM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):